CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will sit on a panel titled "Getting the Funds You Need to Build and Grow Your Company" at the Specialty Pharmaceutical Conference sponsored by the Institute for International Research in Orlando.
News | 04. 11. 2007
